Top News

MARKET TRENDS

6 Jun 2025

As COVID Demand Shrinks, Vaccine Makers Rethink Their Strategy

With tighter rules and a smaller market, mRNA leaders refocus on high-risk groups and aim to sharpen delivery and messaging.

INVESTMENT

12 Jan 2026

A New Pulse in Biotech IPOs Starts With Oncology

Thermo Fisher Scientific building exterior representing mRNA partnership expansion

PARTNERSHIPS

15 Jun 2025

mRNA Momentum Builds as Ethris and Thermo Fisher Join Forces

Latest News

PARTNERSHIPS
13 Jan 2026
AI Alliance Refines RNA Cancer Drug Discovery
INVESTMENT
12 Jan 2026
A New Pulse in Biotech IPOs Starts With Oncology
TECHNOLOGY
7 Jan 2026
Can Generative AI Crack the Code of mRNA Design?
RESEARCH
19 Dec 2025
A New Twist Makes mRNA Drugs More Selective

BARDA Pullback Signals New Phase for US mRNA Development

HHS press release signaling reduced BARDA support for mRNA development

REGULATORY

18 Dec 2025

HHS is winding down BARDA-backed mRNA vaccine programs, prompting analysts to see a shift toward commercially focused mRNA strategies

PARTNERSHIPS

15 Jun 2025

mRNA Momentum Builds as Ethris and Thermo Fisher Join Forces

New alliance solves key mRNA production barriers, speeding Ethris's SNIM RNA therapies like lead nasal spray candidate ETH47 toward market...

MARKET TRENDS

6 Jun 2025

As COVID Demand Shrinks, Vaccine Makers Rethink Their Strategy

With tighter rules and a smaller market, mRNA leaders refocus on high-risk groups and aim to sharpen delivery and messaging.

3D illustration of mRNA strands representing emerging in-vivo cancer cell therapy technology

INNOVATION

2 Jun 2025

mRNA Rewrites the Rules of Cancer Cell Therapy

Myeloid's in-body mRNA tech aims to make cancer treatment faster, cheaper, and more widely available.

5 6

SUBSCRIBE FOR UPDATES

By submitting, you agree to receive email communications from the event organizers, including upcoming promotions and discounted tickets, news, and access to related events.